Peter R Brown
Examiner (ID: 14886)
Most Active Art Unit | 3636 |
Art Unit(s) | 3507, 3636, 3508, 3624 |
Total Applications | 3230 |
Issued Applications | 2605 |
Pending Applications | 120 |
Abandoned Applications | 505 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7034377
[patent_doc_number] => 20050032887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Novel lactone compound'
[patent_app_type] => utility
[patent_app_number] => 10/866600
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5318
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866600 | Lactone compound | Jun 9, 2004 | Issued |
Array
(
[id] => 7605323
[patent_doc_number] => 07115606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Method of treating lower urinary tract disorders'
[patent_app_type] => utility
[patent_app_number] => 10/863770
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28704
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863770 | Method of treating lower urinary tract disorders | Jun 6, 2004 | Issued |
Array
(
[id] => 7265368
[patent_doc_number] => 20040242904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent'
[patent_app_type] => new
[patent_app_number] => 10/497370
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6234
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497370 | Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent | Jun 2, 2004 | Abandoned |
10/858554 | Antitumor compositions containing taxane derivatives | Jun 1, 2004 | Abandoned |
Array
(
[id] => 7378078
[patent_doc_number] => 20040220158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => '5-Androsten-3beta-ol steroid intermediates and processes for their preparation'
[patent_app_type] => new
[patent_app_number] => 10/858177
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9470
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858177 | 5-androsten-3β-ol steroid intermediates and processes for their preparation | May 31, 2004 | Issued |
Array
(
[id] => 7117298
[patent_doc_number] => 20050070599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide'
[patent_app_type] => utility
[patent_app_number] => 10/853834
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5872
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10853834
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/853834 | Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide | May 25, 2004 | Abandoned |
Array
(
[id] => 928633
[patent_doc_number] => 07314943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-01
[patent_title] => 'Pyran derivatives containing an exocyclic double bond'
[patent_app_type] => utility
[patent_app_number] => 10/852731
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26196
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314943.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852731 | Pyran derivatives containing an exocyclic double bond | May 24, 2004 | Issued |
Array
(
[id] => 7616885
[patent_doc_number] => 06946556
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-20
[patent_title] => 'Preparation of opioid analgesics by a one-pot process'
[patent_app_type] => utility
[patent_app_number] => 10/851528
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2550
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851528 | Preparation of opioid analgesics by a one-pot process | May 20, 2004 | Issued |
Array
(
[id] => 7276401
[patent_doc_number] => 20040235852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Benzofuran inhibitors of factor VIIa'
[patent_app_type] => new
[patent_app_number] => 10/850231
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22636
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850231 | Benzofuran inhibitors of factor VIIa | May 18, 2004 | Issued |
Array
(
[id] => 448924
[patent_doc_number] => 07250447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Acylsulfamide inhibitors of factor VIIa'
[patent_app_type] => utility
[patent_app_number] => 10/850312
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18791
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850312
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850312 | Acylsulfamide inhibitors of factor VIIa | May 18, 2004 | Issued |
Array
(
[id] => 7427224
[patent_doc_number] => 20040229864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Sulfone derivatives as 5-HT7 receptor ligands'
[patent_app_type] => new
[patent_app_number] => 10/845847
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27496
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845847 | Sulfone derivatives as 5-HT7 receptor ligands | May 13, 2004 | Issued |
Array
(
[id] => 7432502
[patent_doc_number] => 20040209825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto'
[patent_app_type] => new
[patent_app_number] => 10/838766
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9995
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838766 | Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto | May 3, 2004 | Abandoned |
Array
(
[id] => 7319273
[patent_doc_number] => 20040224994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives'
[patent_app_type] => new
[patent_app_number] => 10/832624
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17396
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832624 | Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives | Apr 26, 2004 | Issued |
Array
(
[id] => 1028134
[patent_doc_number] => 06881851
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-19
[patent_title] => 'Preparation of tetrahydro-3-furoic acid'
[patent_app_type] => utility
[patent_app_number] => 10/828728
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2258
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828728 | Preparation of tetrahydro-3-furoic acid | Apr 20, 2004 | Issued |
Array
(
[id] => 956373
[patent_doc_number] => 06956124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-18
[patent_title] => 'Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene'
[patent_app_type] => utility
[patent_app_number] => 10/824030
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2926
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/956/06956124.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824030 | Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene | Apr 13, 2004 | Issued |
Array
(
[id] => 620252
[patent_doc_number] => 07141669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Cannabiniod receptor ligands and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/822988
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25336
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822988 | Cannabiniod receptor ligands and uses thereof | Apr 11, 2004 | Issued |
Array
(
[id] => 616600
[patent_doc_number] => 07145012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Cannabinoid receptor ligands and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/823107
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26791
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/145/07145012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823107 | Cannabinoid receptor ligands and uses thereof | Apr 11, 2004 | Issued |
Array
(
[id] => 7378991
[patent_doc_number] => 20040220258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Materials and methods for treating coagulation disorders'
[patent_app_type] => new
[patent_app_number] => 10/822129
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7546
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220258.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822129 | Materials and methods for treating coagulation disorders | Apr 7, 2004 | Issued |
Array
(
[id] => 7378987
[patent_doc_number] => 20040220257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Mitochrondrial permeability transition pore affinity labels and modulators'
[patent_app_type] => new
[patent_app_number] => 10/817975
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10525
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10817975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/817975 | Mitochrondrial permeability transition pore affinity labels and modulators | Apr 4, 2004 | Issued |
Array
(
[id] => 7466764
[patent_doc_number] => 20040198759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Aporphine and oxoaporphine compounds and pharmaceutical use thereof'
[patent_app_type] => new
[patent_app_number] => 10/817641
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9309
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10817641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/817641 | Aporphine and oxoaporphine compounds and pharmaceutical use thereof | Apr 1, 2004 | Issued |